Related Experiment Video
Updated: Oct 9, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Cardiovascular-specific PSEN1 deletion leads to abnormalities in calcium homeostasis
Xiao-Wei Song1, Feng Zhao1, Jing Yang1,2
1Department of Cardiology, Changhai Hospital, Shanghai, China.
Insights
Presenilin-1 (PSEN1) downregulation in heart failure disrupts calcium (Ca2+) handling in cardiomyocytes, leading to aging-related cardiomyopathy. This finding offers potential therapeutic targets for heart disease treatment.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Genetics of Heart Disease
Background:
- Mutations in Presenilin-1 (PSEN1) are linked to dilated cardiomyopathy.
- Understanding PSEN1's role in cardiomyocytes is crucial for heart disease treatment.
Purpose of the Study:
- To investigate the role of PSEN1 in the heart and its impact on cardiac function.
- To elucidate the mechanisms by which PSEN1 deficiency leads to cardiomyopathy.
Main Methods:
- Cardiovascular-specific PSEN1 knockout mouse model (Sm22a-PSEN1-KO).
- Echocardiography to assess cardiac function.
- Analysis of gene expression.
- Measurement of intracellular calcium (Ca2+) levels in isolated cardiomyocytes and heart tissue.
Main Results:
- PSEN1 was downregulated in ischemia-induced failing hearts.
- PSEN1 deletion in cardiovascular cells caused spontaneous death due to cardiomyopathy.
- PSEN1 knockout mice exhibited reduced ejection fraction and fractional shortening, indicative of heart failure.
- PSEN1 deficiency disrupted Ca2+ homeostasis, increasing cytosolic Ca2+ and decreasing sarcoplasmic reticulum Ca2+ levels.
- Gene expression analysis revealed enrichment in muscle development and dilated cardiomyopathy pathways.
Conclusions:
- Downregulation of PSEN1 in failing hearts disrupts Ca2+ homeostasis.
- Abnormalities in Ca2+ handling due to PSEN1 deficiency may contribute to aging-related cardiomyopathy.
- These findings have implications for the treatment of age-related heart diseases.
Abstract:
Mutations of PSEN1 have been reported in dilated cardiomyopathy pedigrees. Understanding the effects and mechanisms of PSEN1 in cardiomyocytes might have important implications for treatment of heart diseases. Here, we showed that PSEN1 was downregulated in ischemia-induced failing hearts. Functionally, cardiovascular specific PSEN1 deletion led to spontaneous death of the mice due to cardiomyopathy. At the age of 11 months, the ratio of the heart weight/body weight was slightly lower in the Sm22a-PSEN1-KO mice compared with that of the WT mice. Echocardiography showed that the percentage of ejection fraction and fractional shortening was significantly reduced in the Sm22a-PSEN1-KO group compared with the percent of these measures in the WT group, indicating that PSEN1-KO resulted in heart failure. The abnormally regulated genes resulted from PSEN1-KO were detected to be enriched in muscle development and dilated cardiomyopathy. Among them, several genes encode Ca2+ ion channels, promoting us to investigate the effects of PSEN1 KO on regulation of Ca2+ in isolated adult cardiomyocytes. Consistently, in isolated adult cardiomyocytes, PSEN1-KO increased the concentration of cytosolic Ca2+ and reduced Ca2+ concentration inside the sarcoplasmic reticulum (SR) lumen at the resting stage. Additionally, SR Ca2+ was decreased in the failing hearts of WT mice, but with the lowest levels observed in the failing hearts of PSEN1 knockout mice. These results indicate that the process of Ca2+ release from SR into cytoplasm was affected by PSEN1 KO. Therefore, the abnormalities in Ca2+ homeostasis resulted from downregulation of PSEN1 in failing hearts might contribute to aging-related cardiomyopathy, which might had important implications for the treatment of aging-related heart diseases.
Related Concept Videos
Skeleton and Calcium Homeostasis
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

